These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6699138)

  • 1. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes.
    Reichlin M; Maddison PJ; Targoff I; Bunch T; Arnett F; Sharp G; Treadwell E; Tan EM
    J Clin Immunol; 1984 Jan; 4(1):40-4. PubMed ID: 6699138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes.
    Reimer G; Scheer U; Peters JM; Tan EM
    J Immunol; 1986 Dec; 137(12):3802-8. PubMed ID: 3537125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex.
    Alderuccio F; Chan EK; Tan EM
    J Exp Med; 1991 Apr; 173(4):941-52. PubMed ID: 2007859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antinucleolar antibodies in diagnostics of antiphospholipid syndrome].
    Zabek J; Palacz A; Pyka J; Krzewska I
    Pol Arch Med Wewn; 2008; 118 Suppl():25-30. PubMed ID: 19562966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
    Mahler M; Raijmakers R
    Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.
    Oddis CV; Okano Y; Rudert WA; Trucco M; Duquesnoy RJ; Medsger TA
    Arthritis Rheum; 1992 Oct; 35(10):1211-7. PubMed ID: 1418007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity in polymyositis/dermatomyositis.
    Targoff IN
    J Invest Dermatol; 1993 Jan; 100(1):116S-123S. PubMed ID: 8423380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
    Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
    Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen.
    Mahler M; Raijmakers R; Dähnrich C; Blüthner M; Fritzler MJ
    Arthritis Res Ther; 2005; 7(3):R704-13. PubMed ID: 15899056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
    Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
    Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoserological aspects of idiopathic inflammatory muscle disease.
    Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system.
    Nishikai M; Reichlin M
    Arthritis Rheum; 1980 Aug; 23(8):881-8. PubMed ID: 7406938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
    Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
    Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.
    Muro Y; Hosono Y; Sugiura K; Ogawa Y; Mimori T; Akiyama M
    Arthritis Res Ther; 2015 Mar; 17(1):57. PubMed ID: 25885224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of protein components reactive with anti-PM/Scl autoantibodies.
    Gelpi C; Algueró A; Angeles Martinez M; Vidal S; Juarez C; Rodriguez-Sanchez JL
    Clin Exp Immunol; 1990 Jul; 81(1):59-64. PubMed ID: 2199097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.
    Raijmakers R; Renz M; Wiemann C; Egberts WV; Seelig HP; van Venrooij WJ; Pruijn GJ
    Arthritis Rheum; 2004 Feb; 50(2):565-9. PubMed ID: 14872500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen.
    Treadwell EL; Alspaugh MA; Wolfe JF; Sharp GC
    J Rheumatol; 1984 Oct; 11(5):658-62. PubMed ID: 6334745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?
    Mahler M; Fritzler MJ
    Autoimmun Rev; 2009 Mar; 8(5):373-8. PubMed ID: 19103309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of epitopes recognized by PM/Scl autoantibodies with gene-fragment phage display libraries.
    Blüthner M; Bautz EK; Bautz FA
    J Immunol Methods; 1996 Nov; 198(2):187-98. PubMed ID: 8946014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.